NEW YORK, December 10 – Forest Laboratories, Inc. (NYSE: FRX) announced today the results of a clinical study, which showed that Lexapro TM (escitalopram oxalate) is as effective and well tolerated as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback